About: A consensus guideline of herbal medicine for coronavirus disease 2019

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A consensus guideline of herbal medicine for coronavirus disease 2019 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A consensus guideline of herbal medicine for coronavirus disease 2019
Creator	Lee, Ju Choi, Jun-Yong Jung, Hee-Jae Kim, Kwan-Il Lee, Beom-Joon
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country. METHOD: The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts. RESULTS: Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended. CONCLUSION: The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future.
has issue date	2020-07-05(xsd:dateTime)
bibo:doi	10.1016/j.imr.2020.100470
bibo:pmid	32691002
has license	no-cc
sha1sum (hex)	fca1072fcd14e739290e27e16997a893908ebe9e
schema:url	https://doi.org/10.1016/j.imr.2020.100470
resource representing a document's title	A consensus guideline of herbal medicine for coronavirus disease 2019
has PubMed Central identifier	PMC7335489
has PubMed identifier	32691002
schema:publication	Integr Med Res
resource representing a document's body	covid:fca1072fcd14e739290e27e16997a893908ebe9e#body_text
is schema:about of	named entity 'covered' named entity 'Severe Acute Respiratory Syndrome Coronavirus' named entity 'experts' named entity 'Wuhan' named entity 'ongoing' named entity 'Chinese' named entity 'coronavirus disease 2019' named entity 'COVID-19' named entity 'administration' named entity 'original' named entity 'RESULTS' named entity 'CONSENSUS' named entity 'PREVENTION OF' named entity 'CHINESE MEDICINE' named entity 'BASED' named entity 'WUHAN' named entity 'OUR' named entity 'CLINICAL PRACTICE GUIDELINE' named entity 'herbal medicine' named entity 'medical insurance' named entity 'Wuhan' named entity 'Severe Acute Respiratory Syndrome Coronavirus' named entity 'dialectic' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'herbal medicine' named entity 'lungs' named entity 'medical insurance' named entity 'polymerase chain reaction' named entity 'herbal preparations' named entity 'infection' named entity 'sputum' named entity 'ancient times' named entity 'impact of COVID-19' named entity 'SARS-CoV-2' named entity 'Korean medicine' named entity 'vaccine' named entity 'modern medicine' named entity 'radiologic tests' named entity 'traditional medicine' named entity 'symptomatic treatment' named entity 'pneumonia' named entity 'Chinese government' named entity 'Delphi method' named entity 'body aches' named entity 'COVID' named entity 'cough' named entity 'herbal preparations' named entity 'anhidrosis' named entity 'exposure to the virus' named entity 'Korea' named entity 'herbal medicines' named entity 'lungs' named entity 'sore throat' named entity 'SARS-CoV-2' named entity 'chest tightness' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'herbal decoction' named entity 'respiratory symptoms' named entity 'SARS-CoV-2' named entity 'herbal preparations' named entity 'Korea' named entity 'clinical practice guideline' named entity 'infection' named entity 'Chinese government's' named entity 'herbal medicine' named entity 'Hubei Province, China' named entity 'Korean medicine' named entity 'SARS-CoV-2' named entity 'herbal medicine' named entity 'pneumonia' named entity 'respiratory symptoms' named entity 'sputum' named entity 'lungs' named entity 'infectious diseases' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software